Fig. 5

Utilization of established CC PDX models for evaluating patient’s response to chemotherapy. a, e Imaging of cervical cancer lesions in the patient pre- and post-treatment. b, f The volumes of PBS and DDP treated PDX tumors. c, g Representative images of hematoxylin and eosin-stained section and Ki67 staining of PBS and DDP treated PDX tumors; scale bar, 50 μm. d, h Quantitation of the Ki67 staining in the epithelial fraction (CAT105, n = 4; CAT001, n = 5). ^*p < 0.05, ^**p < 0.01, NS, not significant